It is suspected that these benefits apply to other patient populations, although there are insufficient data to support such speculations, particularly in obese patients with AID
Role of leptin and adiponectin in insulin resistance
Torrioli MG, Vernacotola S, Mariotti P, et al
Considering the promising results of the SURPASS and SURMOUNT trials, what additional factors or challenges must researchers address before adopting tirzepatide for conditions beyond Type 2 diabetes, such as non-alcoholic fatty liver disease (NAFLD)
Additionally, the NHS Greater Glasgow and Clyde in the UK was the study sponsor
For intensive overnight care, apply 2-3 times the usual amount as a sleeping mask AI-generated from the product information